Scientific Industries, Inc. Reports Increases in Sales and Net Income Results


BOHEMIA, N.Y., Feb. 13, 2004 (PRIMEZONE) -- Scientific Industries, Inc. (OTCBB:SCND) announces increased sales and profits for the three and six months ended December 31, 2003.

Based on unaudited results, the Company reported, primarily as a result of increased sales of new products, an increase of $36,000 (4%) in net sales to $869,700 for the three months ended December 31, 2003 versus $833,700 for the same period last year, and an increase of $59,600 (4%) to $1,743,600 in net sales for the first six months of the current fiscal year compared to $1,684,000 for the same period last year.

The Company realized substantially higher pre-tax income of $80,700 and $125,700 for the three and six months ended December 31, 2003, compared to losses of $8,300 and $300 for the same periods last year. The increases in pre-tax income were mainly due to higher gross profits, which benefited from lower production costs. The Company's general and administrative expenses were significantly lower for both periods because the prior year periods included expenses related to an unsuccessful proxy contest initiated by the Company's former chief executive officer as well as his termination costs. Although the company's selling and research and development expenses were significantly higher due to the company's expansion of its marketing and selling activities and accelerated new product development, it benefited from the lower general and administrative expenses, which substantially offset the increased expenses.

Net income for the three and six months ended December 31, 2003 was significantly higher at $60,700 ($.06 per basic share) and $90,700 ($.09 per basic share) versus net losses of ($6,900) ($.01 per basic share) and ($300) ($.00 per basic share) for the same periods last year.

About Scientific Industries

Scientific Industries manufactures and markets laboratory equipment, including the world-renowned Vortex-Genie(r) 2 Mixer. Scientific's products are used by research laboratories, clinics, pharmaceutical manufacturers, medical device manufacturers, and other industries.

"Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-KSB."


              SCIENTIFIC INDUSTRIES, INC. AND SUBSIDIARY
            UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEET

                                             December 31, 2003
    ASSETS

 Current Assets                                  $2,029,000
 Property and Equipment, Net                        159,500
 Deferred Taxes                                     113,600
 Other Assets and Deferred Charges                   96,600
                                                 ----------
      Total Assets                               $2,398,700
                                                 ==========

   LIABILITIES AND SHAREHOLDERS' EQUITY

 Current Liabilities                             $  265,900
 Deferred Compensation                               52,100
 Shareholders' Equity                             2,080,700
                                                 ----------
      Total Shareholders' Equity & Liabilities   $2,398,700
                                                 ==========


                      SCIENTIFIC INDUSTRIES, INC.
       UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                      For the Three Month       For the Six Month
                          Periods Ended           Periods Ended
                          December  31,           December 31,
                     ---------------------   ----------------------
                        2003        2002        2003        2002
                     ----------  ---------   ----------  ----------

 Net Sales           $  869,700  $ 833,700   $1,743,600  $1,684,000
                     ----------  ---------   ----------  ----------
 Gross Profit           401,500    339,100      810,500     686,900
                     ----------  ---------   ----------  ----------
 Income (Loss)
  from Operations        76,200     (8,700)     118,600      (4,800)
 Interest and
  Other Income            4,500        400        7,100       4,500
                     ----------  ---------   ----------  ----------

 Income (Loss)
  Before Income
  Taxes (Benefit)        80,700     (8,300)     125,700        (300)

 Income Taxes
  (Benefit)              20,000     (1,400)      35,000          --
                     ----------  ---------   ----------  ----------
 Net Income (Loss)   $   60,700  $  (6,900)  $   90,700  $     (300)
                     ==========  =========   ==========  ==========

 Net Income (Loss)
  per common share
  - basic:           $      .06  $    (.01)  $      .09  $       --

 Net Income (Loss)
  per common share
  - diluted:         $      .06  $    (.01)  $      .09  $       --

 Weighted average
  number of
  outstanding shares:
   Basic                960,541    954,541      960,541     952,591
   Diluted            1,005,820    954,541      997,660     952,591

The Scientific Industries company logo can be found at: http://media.primezone.com/prs/single/?pkgid=715



            

Kontaktdaten